Ridwaan Jhetam
About Ridwaan Jhetam
Ridwaan Jhetam is the SVP and Head of Worldwide Medical Affairs Hematology at Bristol Myers Squibb and a Visiting Senior Lecturer at King's College London, with over 22 years of experience in the pharmaceutical industry.
Company
Ridwaan Jhetam currently holds the position of SVP: Head of Worldwide Medical Affairs Hematology at Bristol Myers Squibb. As part of his role, he oversees global medical affairs strategies in hematology, playing a crucial part in advancing the company's expertise and product offerings in this therapeutic area. His role involves strategic decision-making, collaboration with Key Opinion Leaders, and ensuring the commercialization and lifecycle management of hematology products.
Title
Ridwaan Jhetam serves as the Senior Vice President (SVP) and Head of Worldwide Medical Affairs for Hematology at Bristol Myers Squibb. Additionally, he is a Visiting Senior Lecturer at King's College London's Department of Cancer & Pharmaceutical Sciences: Faculty of Life Sciences & Medicine located in London, England, United Kingdom. These positions allow him to contribute significantly to both industry and academia.
Education and Expertise
Ridwaan Jhetam has a diverse educational background with significant achievements. He obtained his MD Medicine from the University of KwaZulu-Natal, followed by an MBChB. He earned an MSc in Clinical Oncology (with Merit) from the University of Birmingham. He also pursued a B.Sc Honours in Clinical Pharmacology from the University of Potchefstoom and an MBA from the University of the Witwatersrand. His extensive education provides a robust foundation for his roles in medical affairs, clinical research, and oncology.
Professional Background
Ridwaan Jhetam has over 22 years of experience in the pharmaceutical industry with significant roles in multiple global companies. At GSK, he served as VP Oncology Medical Affairs Head Europe from 2019 to 2021. Prior to that, he was the Associate Vice President: Oncology Medical Affairs Regional Medical Lead: EMEAC at MSD from 2015 to 2019. He also held positions at GSK as Oncology Medical Director: Middle East & Africa & CIS from 2011 to 2014 and at Johnson & Johnson as Senior Director: Global Clinical Operations Head of Oncology from 2006 to 2011. His career began with roles at Tibotec, The Janssen Pharmaceutical Companies of Johnson & Johnson, and Janssen-Cilag.
Specialization and Leadership
Ridwaan Jhetam specializes in drug development, medical governance, product commercialization, lifecycle management, and healthcare systems across the US, Europe, and Emerging Markets. He has designed and implemented clinical development and medical affairs strategies for hematology/oncology products, including biologics, cytotoxics, targeted therapy, small molecules, immunotherapies, and CAR-T cell therapies. Additionally, he has built and led high-performing teams on three continents and is an active member of various Senior Leadership Teams and Governance Committees responsible for therapeutic area portfolio strategic decisions.